Japanese Pharmaceuticals & Biotech Big Green Snowflakes

Shionogi

Market Cap: JP¥2.3t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

KYORIN Pharmaceutical

Market Cap: JP¥85.3b

Through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally.

Daiichi Sankyo Company

Market Cap: JP¥7.0t

Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.

Santen Pharmaceutical

Market Cap: JP¥520.7b

Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

Otsuka Holdings

Market Cap: JP¥4.7t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Takeda Pharmaceutical

Market Cap: JP¥7.1t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.

Hisamitsu Pharmaceutical

Market Cap: JP¥297.1b

Manufactures and sells pharmaceuticals in Japan.

Nippon Shinyaku

Market Cap: JP¥245.9b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

Sawai Group Holdings

Market Cap: JP¥224.6b

Together with subsidiaries, engages in the research and development, manufacture, and marketing of generic pharmaceuticals.

Towa Pharmaceutical

Market Cap: JP¥156.1b

Manufactures and sale ethical drugs in Japan.

Kyowa Kirin

Market Cap: JP¥1.4t

Engages in the research, development, manufacture, import/export, and market of pharmaceuticals products worldwide.

Tsumura

Market Cap: JP¥290.8b

Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.

Kissei Pharmaceutical

Market Cap: JP¥193.0b

Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.

Shin Nippon Biomedical Laboratories

Market Cap: JP¥73.4b

A contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally.

Kidswell Bio

Market Cap: JP¥12.1b

Develops pharmaceutical products for the treatment of pediatric, pediatric, intractable, and Asia-endemic diseases in Japan.

Astellas Pharma

Market Cap: JP¥3.5t

Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.

ASKA Pharmaceutical HoldingsLtd

Market Cap: JP¥58.0b

Through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan.

Zeria Pharmaceutical

Market Cap: JP¥89.7b

Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally.

Eisai

Market Cap: JP¥1.4t

Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals.

Chugai Pharmaceutical

Market Cap: JP¥13.9t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Fuji Pharma

Market Cap: JP¥42.3b

Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.

Daito PharmaceuticalLtd

Market Cap: JP¥38.2b

Engages in the manufacture and sale of pharmaceutical products worldwide.

Noile-Immune Biotech

Market Cap: JP¥6.8b

Researches and develops CAR-T cells for cancer immunotherapies.

Sumitomo Pharma

Market Cap: JP¥1.1t

Engages in manufacture, purchase, and sale of pharmaceutical products for medical treatment in Japan, North America, and Asia.

Takara Bio

Market Cap: JP¥101.5b

Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.

Human Metabolome Technologies

Market Cap: JP¥3.8b

Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan.

GNI Group

Market Cap: JP¥142.0b

Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.

Kaken Pharmaceutical

Market Cap: JP¥144.3b

Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.

Mochida Pharmaceutical

Market Cap: JP¥120.4b

Manufactures and sells pharmaceuticals and healthcare products in Japan.

WDB coco

Market Cap: JP¥6.3b

Provides contract and human resource services to pharmaceutical companies in Japan.

Ono Pharmaceutical

Market Cap: JP¥1.0t

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

atect

Market Cap: JP¥2.2b

Engages in the sanitation inspection equipment, powder injection molding (PIM), and semiconductor material businesses.

Nippon Chemiphar

Market Cap: JP¥5.5b

Engages in the manufacture, sale, import, and export of ethical pharmaceuticals and diagnostic agents in Japan and internationally.

Kohjin Bio

Market Cap: JP¥7.9b

Manufactures and sells animal blood, sera, tissue culture media, agar media for microorganism tests, in-vitro diagnostic agents, and cosmetics.

Linical

Market Cap: JP¥6.8b

A global contract research organization provides full spectrum of drug development services to pharmaceutical companies worldwide.

CellSource

Market Cap: JP¥10.0b

Engages in the regenerative medicine-related businesses in Japan.